Hepatocellular Expression of Macrophage Migration Inhibitory Factor (MIF) Is Associated with Ischemia-Reperfusion Injury After Liver Transplantation
Authors:
- Pontes FilhoPFPontes Filho
- Rodrigo Humberto VilarRVRodrigo Humberto Vilar
- Camila Xavier BritoCBCamila Xavier Brito
- Serena Dáfne Do Carmo SilvaSSSerena Dáfne Do Carmo Silva
- Agnaldo Soares LimaALAgnaldo Soares Lima
- Francisco Guilherme Cancela E PennaFPFrancisco Guilherme Cancela E Penna
- Fernanda Maria Farage OsórioFOFernanda Maria Farage Osório
- Fernanda Maria FarageFFFernanda Maria Farage
- Níkolas Knupp ThomeNTNíkolas Knupp Thome
- Cristiano Xavier LimaCLCristiano Xavier Lima
- Paula Vieira Teixeira VidigalPVPaula Vieira Teixeira Vidigal
Open Access
- 1 January 2026
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Abstract
Introduction: Ischemia-reperfusion injury (IRI) is a major determinant of initial graft function after liver transplantation (LT), directly influencing the incidence of early dysfunction and short-term clinical outcomes. Macrophage migration inhibitory factor (MIF), a pleiotropic cytokine involved in inflammatory pathways and mechanisms of cellular adaptation to oxidative stress, may play a modulatory role in IRI, although its immediate tissue behaviour in grafts remains poorly characterised. Methods: We retrospectively evaluated adult LT recipients who underwent post-reperfusion biopsies suitable for histological and immunohistochemical analysis. Immunohistochemical expression of MIF was quantified using the IHC Profiler plugin (ImageJ), whereas IRI was graded according to validated histopathological criteria. Results: Among 153 biopsies analysed, 103 met the eligibility criteria, with most cases showing absent or mild IRI (70.9%). Hepatocellular expression of MIF was predominantly weak or moderate. Stronger immunohistochemical staining for MIF was associated with lower IRI severity (p<0.05). MIF expression correlated with pre-transplant laboratory parameters, without association with steatosis or early outcomes, including retransplantation or death within 15 days. Conclusion: The findings suggest that greater immunohistochemical expression of MIF at reperfusion is associated with lower IRI intensity, indicating a possible adaptive role for this cytokine during this critical phase. MIF emerges as a potential tissue marker complementary to traditional histopathological scoring, with relevance for graft assessment and use in contemporary liver perfusion strategies.Keywords
This publication has 26 references indexed in Scilit:
- Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategiesPharmacology & Therapeutics, 2022
- Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver TransplantationJournal of Clinical and Experimental Hepatology, 2022
- Macrophage p38α promotes nutritional steatohepatitis through M1 polarizationJournal of Hepatology, 2019
- Analysis of ischemia/reperfusion injury in time‐zero biopsies predicts liver allograft outcomesLiver Transplantation, 2014
- Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)Journal of Hepatology, 2012
- Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in ratsCytokine, 2012
- Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factorsLiver Transplantation, 2010
- Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heartNature, 2008
- Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disordersJournal of Gastroenterology, 2005
- Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in VivoThe American Journal of Pathology, 2003